Story perspectives

U.S. AI Strategy: Nationalism vs. China's Collaboration

9/5/2025

Center

Trump's AI Dominance

The Trump administration's AI Action Plan promotes U.S. innovation and regulatory easing to achieve AI dominance, differing from China's collaborative strategy.
Both nations stress improved infrastructure for AI, with the U.S. adopting a nationalistic stance and China favoring global cooperation.
The U.S. aims to reduce pharmaceutical dependency on China through targeted tariffs, prioritizing national security while protecting allies.
The potential termination of the International Development Finance Corporation (DFC) raises concerns about U.S. competitiveness against China's Belt and Road Initiative.
Quality issues at the U.S. Patent and Trademark Office threaten innovation, as low-quality patents hinder competition and benefit foreign entities.

Right

Wang Advocates Engineering

"Abundance" and Dan Wang's "Breakneck: China’s Quest to Engineer the Future" explore U.S.-China relations.
Wang contrasts China's engineering-driven approach with the U.S. legal-centric system, impacting infrastructure development.
China has successfully built extensive infrastructure, while U.S. projects struggle with delays and bureaucracy.
He urges the U.S. to refocus on engineering and diversify leadership beyond lawyers.
Wang expresses optimism about America's ability to revive its construction ethos.

History

Historical Context

The 1989 Tiananmen Square protests exposed China's authoritarian regime, contrasting with U.S. democratic values. In response, the U.S. invested over $8 billion annually in research through the National Science Foundation. Today, the U.S. AI Action Plan reflects a competitive stance against China's rapid advancements in technology, particularly as China leads in patent filings, accounting for over half of global contributions.

1 of 3

Trump's AI Dominance

The Trump administration's AI Action Plan promotes U.S. innovation and regulatory easing to achieve AI dominance, differing from China's collaborative strategy.
Both nations stress improved infrastructure for AI, with the U.S. adopting a nationalistic stance and China favoring global cooperation.
The U.S. aims to reduce pharmaceutical dependency on China through targeted tariffs, prioritizing national security while protecting allies.
The potential termination of the International Development Finance Corporation (DFC) raises concerns about U.S. competitiveness against China's Belt and Road Initiative.
Quality issues at the U.S. Patent and Trademark Office threaten innovation, as low-quality patents hinder competition and benefit foreign entities.

1 / 3